A new Focus Group devoted to Biomolecules and Vaccines has recently been formed This group will serve members interested in the fast-growing Biopharmaceuticals sector, an area which faces unique challenges with respect to discovery, formulation and delivery of new products and therapies. 

The intention is to provide a dynamic forum spanning both industry and academia which is able to engage with and influence current and future issues relating to the science, technology & regulation of this field. The group will collaborate and coordinate with other organizations and Focus Groups and provide continuing education for the membership via biennial symposia and focused workshops..

The Focus group will be formally launched this year at BPC 2006 at an inaugural Therapeutic Biomolecule and Vaccine session chaired by Kevin King (Pfizer) and Barry D. Moore (XstalBio). The speakers at what promises to be an excellent introduction to this important field will be

• Dr Astrid Pappenberger F. Hoffmann-La Roche Ltd.
• Dr Karoline.Bechtold-Peters Boehringer Ingelheim Pharma GmbH & Co.KG
• Dr. Pierandrea Esposito Sitec Consulting
• Prof. Dr. Tudor Arvinte Therapeomic Inc.

The Focus Group are currently seeking industrial and academic members who may be interested in joining a steering committee to promote the group's activities and plan future symposia and workshops. 

If you would be interested in joining this Focus Group or serving on the steering committee, please contact [email protected] OR [email protected]